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Physical Examination Variables Predict Response to Conservative
Treatment of Nonchronic Plantar Fasciitis: Secondary Analysis of a
Randomized, Placebo-Controlled Footwear Study
James S. Wrobel, DPM, MS, Adam E. Fleischer, DPM, MPH,
Jonathon Matzkin-Bridger, DPM, Jeanna Fascione, DPM, Ryan T. Crews, MS,
Nicholas Bruning, BS, Beth Jarrett, DPMAbstractBackground: Plantar fasciitis is a common, disabling condition, and the prognosis of conservative treatment is difficult to predict.
Objective: To determine whether initial clinical findings could help predict patient response to conservative treatment that
primarily consisted of supportive footwear and stretching.
Setting: Patients were recruited and seen at 2 outpatient podiatric clinics in the Chicago, Illinois, metropolitan area.
Patients: Seventy-seven patients with nonchronic plantar fasciitis were recruited. Patients were excluded if they had a heel
injection in the previous 6 months or were currently using custom foot orthoses at the time of screening. Sixty-nine patients
completed the final follow-up visit 3 months after receiving the footwear intervention.
Methods: Treatment failure was considered a <50% reduction in heel pain at 3 month follow-up. Logistic regression models
evaluated the possible association between more than 30 clinical and physical examination findings prospectively assessed at
enrollment, and treatment response.
Results: Inability to dorsiflex the ankle past 5 (odds ratio [OR] 3.9, P ¼ .024), nonsevere (7 on ordinal scale) first-step pain (OR
3.8, P ¼ .021), and heel valgus in relaxed stance (OR 4.0, P ¼ .014) each predicted treatment failure in multivariable analysis
(receiver operating characteristic area under the curve ¼ .769). Limited ankle dorsiflexion also correlated with greater heel pain
severity at initial presentation (r ¼  0.312, P ¼ .006).
Conclusions: Patients with severe ankle equinus were nearly 4 times more likely to experience a favorable response to treatment
centered on home Achilles tendon stretching and supportive therapy. Thus, earlier use of more advanced therapies may be most
appropriate in those presenting without severe ankle equinus or without severe first step pain. The findings from our study may
not be clinically intuitive because patients with less severe equinus and less severe pain at presentation did worse with con-
servative care.Introduction
Plantar fasciitis is the most common cause of plantar
heel pain [1,2] and is an ongoing recognized economic
burden. It is commonly defined as an overload injury of
the proximal plantar fascia at the infracalcaneal inser-
tion. Some studies suggest plantar fasciitis is more
common in athletes [3] and those who are obese [4].
Others report it affects approximately 10% of both the
general and running populations [1]. In the United States,
it accounts for nearly 1 million patient visits each year
[5], and direct costs associated with prescription therapy1934-1482/$ - see front matter ª 2016 by the American Academy of Physi
http://dx.doi.org/10.1016/j.pmrj.2015.09.011and outpatient visits alone exceed 284 million dollars
annually [6]. Plantar fasciitis has a significant negative
impact on general health-related quality of life that is
independent of body mass index [7].
The primary etiology of plantar fasciitis is unknown,
and there is not a large body of evidence supporting one
treatment over another. In the vast majority of cases,
symptoms are resolved within a year of onset, regard-
less of treatment type [8]. There are multiple treatment
options, available including stretching, foot orthoses,
corticosteroid injections, night splints, extracorporeal
shock wave therapy, and surgery [9]; however, it iscal Medicine and Rehabilitation
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require surgery [10]. Considerable research exists on the
effectiveness of various treatments [11-15] and on fac-
tors associated with the development of plantar fasciitis
[16-19]. Evidence for factors predictive of a positive or
negative outcome with the use of supportive foot
therapy and patient-directed interventions for plantar
fasciitis, however, is absent from the current literature.
With the more recent paradigm shift that is starting
in the United States health care system that supports
value-based payment dependent on patient outcomes,
it is imperative this condition be treated in a more
efficient and effective manner. The primary aim of this
study was to determine whether clinical findings
observed during initial presentation can be predictive of
treatment response in patients receiving conservative,
supportive therapy for nonchronic plantar fasciitis. A
secondary aim was to determine which, if any, baseline
observations are associated with degree of functional
impairment and/or heel pain severity.Materials and MethodsParticipantsThis was a secondary data analysis of 77 subjects who
participated in a randomized controlled trial
(ClinicalTrials.gov Identifier NCT00765843) to evaluate
the efficacy of 3 different foot orthoses conditions for
the treatment of proximal plantar fasciitis [20]. All
participants were ambulatory adult men and women
with nonchronic heel pain (ie, symptoms for less than
12 months). All subjects were recruited from 2 podiatry
specialty clinics located in the greater Chicago metro-
politan area. The data analysis received an exempt
status determination from the Institutional Review
Board.
All included patients had pain at the plantar fascial
attachment to calcaneal tubercle and/or pain distal
from the tubercle along the plantar fascial band with
typical poststatic dyskinesia or pain with activity after
rest. Patient history, physical examination, plain
radiograph assessment, and diagnostic ultrasound were
used to rule out other etiologies of heel pain, including
proximal or local nerve entrapment, arthritis, bone cyst
or tumor, or stress fracture.
Patients with a previous heel injection within the
past 6 months or who were currently using custom foot
orthoses were excluded. Patients with any of the
following pathologies also were excluded: proximal
musculoskeletal pathology (eg, knee or hip arthritis,
sciatica secondary to back pathology, significant limb
length discrepancy), use of gait assistive devices (eg,
crutches, canes, walkers), inability to wear supportive
closed toed shoes, or lack of range motion at the first
metatarsophalangeal or subtalar joints.Overall Study DesignDetails regarding the full randomized controlled trial
can be found in a previous publication [20]. To summarize,
77 patients met the eligibility criteria and agreed to
participate. Patients were randomized at their screening
visit into 1 of 3 treatment groups: custom foot orthoses,
prefabricated orthoses, or sham orthoses. Participants and
investigators were blinded to group allocation. Blinding
waspossiblebyusing thesame3-mmneoprenetopcoveron
each type of orthoses and providing each subject with
standardized shoes (Brooks Dyad, Brooks Sports Inc.,
Bothell WA) in which the orthoses were to be worn.
All participants received a standardized baseline
assessment, including a comprehensive lower extremity
biomechanical examination during the screening/
enrollment visit from a single examiner. The same single
examiner also measured the shoes, casted the patient,
fit, and dispensed the orthoses and shoes. Treatment
also was instituted at that time. Participants were
evaluated again at 1 and 3 months for follow-up. Those
patients reporting less than 50% improvement in their
heel pain symptoms (using an average of their ordinal
pain scale first step and end-of-day pain scores) at
3-month follow-up were classified as having had an un-
favorable treatment response, whereas those reporting
greater than or equal to 50% improvement were classi-
fied as having had a favorable treatment response.AssessmentsEach participant completed an ordinal pain scale
(1-10) first step pain, end-of-day pain, and Foot Func-
tion Index-Revised (FFI-R) surveys regarding their study
foot at enrollment. These scales are recognized as
reliable and valid outcomes measures [11,21,22]. Pa-
tients completed these instruments in a private exami-
nation room during the visit. Information regarding
other potential covariates including, but not limited to,
age, gender, duration of symptoms, height, weight,
laterality, foot type, duration of symptoms, and coex-
isting medical conditions also was recorded (Table 2).
Additionally, a standardized lower extremity biome-
chanical examination was performed by a single podi-
atric physician with greater than 20 years of experience
(B.J.). The biomechanical examination measurements
were performed via the techniques described (B.J.)
[23]. The measurements were performed with a stan-
dard goniometer, with all measurements being done off-
weight-bearing except the stance positions (relaxed and
neutral calcaneal stance positions and tibial influence).
Limb length was measured off-weight-bearing with a
standard measuring tape, and the physician measured
the anterior superior iliac spine to the medial malleolus
and the umbilicus to the medial malleolus.
In addition, visual gait analysis was performed to
facilitate identification of asymmetries consistent with
438 Treatment Response to Nonchronic Plantar Fasciitislimb length inequality. Ankle joint dorsiflexion, specif-
ically, was measured off-weight-bearing both with the
knee flexed and the knee extended. The patient was
placed in a supine position, and the subtalar joint was
slightly supinated. A goniometer was aligned such that
one arm of the goniometer bisected the shaft of the
fibula on the lateral side of the leg, and the other arm
was aligned with the lateral border of the foot. The
ankle joint was manually dorsiflexed to first resistance.
Ankle joint dorsiflexion with the knee extended was
measured first.
The physical examination variables assessed are
provided in Table 3. In addition, we explored for
different foot types previously believed to be important
in plantar fasciitis and favorable treatment response.
These included hallux limitus [24], functional hallux
limitus, hypermobile 1st ray, compensated forefoot
varus, and uncompensated rearfoot varus. Participants
again completed all questionnaires regarding their study
foot at their 1- and 3-month follow-up visits.Conservative Treatment ProtocolOutside of the type of foot orthoses and shoes
received, all patients were placed on the same patient-
directed heel pain treatment protocol [9]. During theFigure 1. (A) Stair stretchscreening process participants were casted for orthoses
and provided removable longitudinal and metatarsal
pads fashioned from a quarter-inch felt for use until
their orthoses were distributed at the baseline visit. One
investigator (B.J.) measured and dispensed all study
shoes. At baseline, only 11% of patients presented with
appropriately fitting shoes when measured from heel-
to-ball of foot. Sixty-one percent of patients had one
size or greater difference when using heel-to-ball of
foot measure. Patients were instructed to wear shoes
and foot supports (initially longitudinal and metatarsal
pads until orthoses were provided) at all times when
ambulating. They were also instructed to avoid going
barefoot and to avoid the use of ladders. Patients were
asked to perform Achilles tendon stretches using both a
stair (Figure 1A) and a wall (Figure 1B, runner’s stretch)
3 times daily (typically before or after meals) for a total
of 1 minute each. Specifically, participants were
instructed to perform an initial passive stretch for
30 seconds followed by a deeper stretch for the
remaining 30 seconds. This technique was demonstrated
by the examiner, and comprehension of the stretching
technique was assessed at each study visit.
Patient adherence was assessed at 1 month and at
3 months’ follow-up with a simple questionnaire that
requested the number of days the patient performed. (B) Runner’s stretch.
439J.S. Wrobel et al. / PM R 8 (2016) 436-444stretching and the average number of times per day.
Patients also were asked to moderate their recreational
activities until their pain had improved. Additionally,
they were instructed to avoid nonsteroidal anti-
inflammatory drugs and instead asked to perform ice
massage to the symptomatic heel for 20 minutes per
hour, for as long as necessary at the end of the day, as a
method of controlling inflammation. Patients also were
asked about other anti-inflammatory medication they
may have been taking. Written instructions and paper
cups for ice massage were provided. A rescue analgesia
protocol consisting of supplied acetaminophen was
incorporated into the study. Patients were asked to use
the acetaminophen as little as possible and were pro-
vided a diary to track their use of it. Lastly, patients were
notified that if their pain was still severe after 3 months
of orthoses use, they would have the option to receive a
steroid injection.Statistical AnalysisTable 1
Demographic and baseline clinical characteristics of participants with
3-month follow-up (n ¼ 69)




Age, y 49.7  12.4 (23-75)
BMI, kg/m2 31.5  7.2 9 (19.5-60.8)
Duration of heel pain, mo 5.27  3.2 (0.25-12)
Time spent standing, h/d 2.9  2.8 (0.25-15)
Pain level
First step 6.6  2.2 (2-10)
End of day 5.7  2.3 (2-10)
BMI ¼ body mass index.For patients presenting with bilateral heel pain, the
study foot was chosen as the more symptomatic foot or,
in the case of equal symptoms, the patient’s dominant
foot was used. Pearson correlation coefficient (r) was
used to examine for correlation between the study’s
continuous clinical covariates and pain level and
disability scores. Patient demographic and baseline
characteristics were stratified by treatment response
(favorable versus unfavorable). Univariate logistic
regression models were used to identify candidate var-
iables associated with treatment response. Variables
with P value thresholds <.10 were tested in the multi-
variable analysis. Receiver operating characteristic
curves were used to identify cut points for continuous
candidate variables and these were also tested for sig-
nificance in multivariable models. The final multivari-
able model was determined using stepwise logistic
regression with P < .05 as the criterion for model entry
and P  .05 for removal. Missing values were imputed
with the mean value for the study population during the
multivariable analysis.
A sensitivity analysis also was performed to evaluate
the influence of participants lost to follow-up (n ¼ 8), by
including them as nonresponders. Although there were
no significant baseline differences between those lost to
follow-up and those completing the study, the average
baseline AM pain was 5.71 versus 4.78 for those that
completed, PM pain 5.71 versus 4.68 for those that
completed, and age 44.9 years versus 49.6 years for
those that completed. All P values less than .05 were
considered significant, and all were 2 tailed. Estimates
of risk were given by odds ratios and 95% confidence
intervals. SAS (Statistical Analysis System, SAS In-
stitute Inc., Cary, NC) version 9.2 was used for all data
analysis.ResultsDescriptive StatisticsSixty-nine of seventy-seven participants (89.6%)
returned for reassessment at 3 months. Characteristics of
the study population with complete follow-up data are
provided in Table 1. The study population consisted
mostly of white women with mildly obese habitus. The
average duration of heel pain at initial presentation was
slightly more than 5 months (5.27  3.2 months [range
0.25e12]). Twenty-one participants presented with
bilateral heel pain (21/69, 30%). Full compliance with
stretching (defined as >80% of the days) was reported in
greater than 50% of the study population at both 1-month
and 3-month follow-ups (38/66, 58% [3 missing] and
38/68, 56% [1 missing], respectively). More than 80% of
the study population stretched on more than half of the
study days (53/66, 80% at 1 month and 57/68, 84% at
3 months). Participants admitted to stretching for a mean
2.6 1.4 times per day (range 0e10) at 1-month follow-up
and 2.2  1.3 times per day (range 1e10) at 3-month
follow-up. No participant admitted to using nonsteroidal
anti-inflammatory drugs during the study period.Clinical Findings Associated With Treatment
ResponseTable 2 displays the distribution of select baseline
characteristics, including foot support allocation and
pain/disability scores, stratified by treatment re-
sponse. Treatment response was not associated with
the type (sham, prefabricated, or custom orthoses) of
foot orthoses received (P > .10). Table 3 describes the
distribution of baseline biomechanical examination
variables stratified by treatment response. Of the var-
iables examined in the univariate analysis, hip internal
rotation (with hip extended, P ¼ .008), hip neutral
position (with hip extended, P ¼ .016), relaxed calca-
neal stance position (P ¼ .035), heel valgus in relaxed
stance (P ¼ .013), ankle joint range of motion
Table 2
Demographics, historical variables, and baseline pain/disability scores






(n ¼ 30) P Value
Demographics
Age 50.5 (10.9) 48.7 (14.2) .565
Female gender 25 (0.64) 19 (0.63) .947
BMI 31.6 (6.2) 31.5 (8.5) .960
Race/ethnicity .69/.13/.10/.08 .69/.03/.24/.03 .246
Historical variables
Study foot ¼ right 16 (.41) 17 (.57) .197
Bilateral symptoms 11 (.28) 10 (.33) .646
Heel pain duration, mo 5.2 (3.4) 5.4 (2.9) .757
Standing time/day, h 3.0 (3.3) 2.8 (2.0) .759
Type of foot support*
Sham orthoses 10 (.26) 13 (.43) .122
Prefabricated orthoses 15 (.38) 6 (.20) .102
Custom orthoses 14 (.36) 11 (.37) .947
Pain/Disability Score
Pain first step 7.0 (2.2) 6.1 (2.2) .095
Pain end-of-day 5.8 (2.3) 5.7 (2.4) .767
FFI-R pain subscale 37.1 (9.2) 35.8 (10.2) .573
FFI-R total 165 (45.5) 164 (40.5) .919
All values are displayed as frequency (percentage of column total) or
as mean (SD); Race/ethnicity presented as percentage of column total
for Caucasian/African American/Hispanic/Other.
t-test or Wilcoxon rank-sum test was used for comparisons of
continuous variables.
c2 or Fisher exact test was used for comparisons of categorical
variables.
BMI ¼ body mass index; FFI-R ¼ Foot Function Index-Revised.
* Logistic regression P value > .10.
Table 3
Baseline lower extremity biomechanical measurements for the study






(n ¼ 30) P Value
Hip and gait measurements
Angle of gait 14.6 (5.3) 12.9 (5.5) .189
Base of gait, cm 7.3 (4.4) 6.5 (3.4) .416
Limb length diff., cm  ASIS 1.5 (13.1) 0.0 (1.8) .532
Limb length diff., cm  umb. 2.1 (14.2) .3 (1.7) .503
Hip internal rotation, hip ext. 16.6 (4.9) 19.8 (4.8) .008*
Hip internal rotation, hip flex 22.5 (5.3) 24.5 (4.9) .129
Hip external rotation, hip ext. 18.6 (5.6) 18.1 (4.1) .661
Hip external rotation, hip flex 20.4 (5.0) 19.4 (4.2) .419
Hip neutral position, hip ext.
support
1.0 (3.2) .87 (3.1) .016*
Hip neutral position, hip flex 1.1 (3.5) 2.5 (3.0) .078
Hip abduction 32.6 (3.9) 32.3 (3.6) .725
Hip adduction 21.9 (3.6) 21.8 (4.5) .942
Hip flexion, knee ext. 42.1 (7.9) 39.7 (8.7) .245
Hip flexion, knee flex 80.0 (12.4) 81.4 (11.5) .635
Hip extension, knee ext. 17.7 (2.9) 17.8 (4.6) .909
Hip extension, knee flex 18.9 (3.4) 18.5 (5.2) .727
Ankle and subtalar joint
Malleolar position 13.7 (2.7) 13.9 (3.0) .735
Tibial influence 1.1 (3.0) .9 (3.1) .802
Ankle dorsiflexion, knee flex 2.6 (5.2) 4.1 (5.2) .242
Ankle dorsiflexion, knee ext. 7.6 (4.9) 5.7 (5.1) .121
Subtalar joint supination 14.5 (4.9) 14.3 (4.1) .885
Subtalar joint pronation 3.1 (2.7) 4.3 (2.3) .069
Subtalar joint neutral pos. 2.8 (2.0) 2.5 (2.0) .445
Subtalar joint neutral pos. calc. 2.7 (2.5) 1.9 (1.7) .133
Relaxed calcaneal stance pos.† 0.7 (3.2) 2.2 (2.3) .035*
Neutral calcaneal stance pos. 5.2 (2.5) 4.3 (3.0) .193
Foot posture index (score) 4.5 (3.5) 5.2 (3.0) .391
All values are displayed as mean (SD); all values are reported in de-
grees unless otherwise specified; all measurements refer to the ipsi-
lateral extremity as the study foot except “base of gait” and “limb
length difference.”
t-test or Wilcoxon rank-sum test was used for comparisons of
continuous variables.
ASIS ¼ anterior superior iliac spine; umb. ¼ umbilicus;
ext. ¼ extended; flex ¼ flexed; pos. ¼ position; calc. ¼ calculated.
* Statistically significant test result.
† A negative number indicates valgus heel position.
440 Treatment Response to Nonchronic Plantar Fasciitis< negative 5 (with knee extended, P ¼ .022), and first
step heel pain 7 (P ¼ .031) were each associated with
treatment response. Other potentially important vari-
ables (P < .10) that were tested in the multivariable
analysis included baseline first step pain, hip neutral
position (with hip flexed), and amount of passive sub-
talar joint pronation. The only significant predictors of
an unfavorable treatment response in the multivariable
analysis were having heel valgus in relaxed stance,
inability to dorsiflex past -5 (with knee extended), and
having first step heel pain 7 at initial presentation
(Table 4). Seventy percent (22/31) of participants with
severe first step heel pain (7/10) responded to
treatment in our study compared to only 45% (17/38) of
those without severe heel pain. Seventy-one percent
(25/35) of participants without heel valgus responded
to treatment compared with 41% (14/34) of partici-
pants with heel valgus. Sixty-seven percent (30/45) of
participants with severe ankle equinus ( neg. 5)
responded compared with only 38% (9/24) of partici-
pants with without severe equinus. We found no dif-
ferences in foot types, including foot posture index,
hallux limitus, functional hallux limitus, hypermobile
1st ray, compensated forefoot varus, and uncompen-
sated rearfoot varus (Table 5).Baseline Observations Associated With
Functional Impairment/Heel Pain SeverityAnkle joint dorsiflexion (with the knee flexed)
demonstrated a moderate correlation with pain and a
modest correlation with disability at initial presentation.
Patients with less ankle joint dorsiflexion generally re-
ported greater end-of-day (r ¼ .357, P ¼ .002) and
greater average heel pain levels (r ¼ .312, P ¼ .006).
Patients with less ankle joint dorsiflexion also tended to
report greater total scores (eg, more disability) on FFI-R
at presentation (r ¼ .303, P ¼ .008).
BMI demonstrated a modest correlation with both
pain and disability scores at initial presentation. Pa-
tients with greater BMI tended to report greater levels
Table 4
Final model for predicting an unfavorable response to conservative








Intercept 2.240 e e .001
Ankle dorsiflexion
< neg. 5
1.368 3.9 1.2-12.5 .021
Heel valgus in
relaxed stance
1.395 4.0 1.3-12.2 .014
AM pain score 7 1.346 3.8 1.2-12.0 .021
Ordinal pain score (1-10).
The area under the receiver operating characteristic curve for this
model ¼ .769. Hosmer-Lemeshow goodness of fit test ¼ 1.836,
P ¼ .934.
* Observations at baseline (patient’s initial presentation); biome-
chanical observations refer to the ipsilateral extremity as the
study foot.
441J.S. Wrobel et al. / PM R 8 (2016) 436-444of end-of-day pain (r ¼ .244, P ¼ .033), greater average
heel pain levels (r ¼ .224, P ¼ .049), greater scores on
the FFI-R pain subscale (r ¼ .268, P ¼ .019), and greater
total disability/dysfunction scores on the FFI-R
(r ¼ .303, P ¼ .008). Participants with greater pain
levels on FFI-R pain subscale also tended to exhibit a
narrower base of gait (r ¼ .302, P ¼ .008).
Finally, Hispanic patients (n ¼ 11) reported greater
first-step heel pain (mean 8.1  1.9 versus 6.5  2.2,
P ¼ .026) and greater average heel pain (mean 8.0  1.5
versus 6.0  1.9, P ¼ .002) levels compared with non-
Hispanic patients. There were no other correlations
observed between demographic, historical, and/or
physical examination characteristics and magnitude of
pain/disability at initial presentation. Furthermore, we
explored treatment response thresholds. There were
only 9 subjects (of 69) who had no pain (visual analog
scale AM þ visual analog scale PM pain ¼ 0) at 3 months,
and 18 (of 69) that had 80% improvement or greater at
3 months. Not surprisingly when these outcomes were
modeled in the multivariate analysis, there were no
significant predictors identified.
In our sensitivity analysis, there were no significant
differences in age, baseline AM pain, and baseline PM
pain for the lost to follow-up group (n ¼ 8) and those
who completed the study. When we included the lost toTable 5







(n ¼ 30) P Value
Hallux dorsiflexion unloaded 44.1 (8.7) 44.4 (11.1) .898
Hallux dorsiflexion loaded 32.6 (8.5) 32.9 (9.8) .746
Functional hallux limitus, diff. 11.5 (6.5) 11.6 (6.5) .925
First ray dorsiflexion, mm 3.3 (1.6) 3.5 (1.5) .867
First ray plantarflexion, mm 5.1 (2.1) 5.3 (1.8) .798
Forefoot varus (25%) compensation 5.7 (4.7) 7.1 (6.1) .438
Rearfoot varus (>4) 30% 14% .164follow-up group as nonresponders and repeated our lo-
gistic model, the effect sizes did not change substan-
tially (data not shown).
Discussion
Studying a compliant patient population with non-
chronic plantar fasciitis, we found that patients with
severe ankle joint equinus were more likely to respond
favorably to a treatment program that centered on
conservative care, including Achilles tendon stretching.
Specifically, patients unable to dorsiflex to at least 5
(with the knee extended) at initial presentation were
nearly 4 times more likely to experience an unfavorable
response at 3 months’ follow-up. Although equinus is
certainly a recognized risk factor for development of
plantar fasciitis [25-27], we believe our study is the first
to actually conclude that more ankle equinus at the
start of therapy translates into improved outcome after
conservative therapy [9].
Our findings are encouraging as they suggest, like
previous work, many people with nonchronic plantar
fasciitis will benefit from conservative care [2]. After
all, 65% (45/69) of the participants in our study exhibi-
ted a severe ankle joint equinus at their initial presen-
tation, and it is well recognized that many individuals
suffering with plantar fasciitis will demonstrate
restricted ankle joint motion [16,25-27]. Despite there
being a lack of clear evidence surrounding the benefit of
Achilles tendon stretching [28], authorities still main-
tain that home Achilles tendon stretching is an integral
part in the conservative management of plantar fasciitis
[29,30]. Our work may help explain the mixed results of
past work. Our protocol relied on stretching, ice mas-
sage, standardized shoes, and altering footwear be-
haviors. Our work also found that stretching alone was
not enough for experiencing relief. More specifically, we
found that the amount of stretching (ie, days or times
per day) determined by patient self-report was not
associated with a favorable treatment response
(P > .05). Therefore, it may be that it is the combined
effect of regular stretching along with an initial severe
posterior muscle group tightness that favors a good
response to treatment. Our study was underpowered to
fully examine this interaction effect, but future work is
probably warranted to further explore this effect.
Subjects with a valgus rearfoot position in relaxed
stance were also more likely to experience an unfavor-
able response to treatment. There is some limited evi-
dence that suggests that patients with pronated feet may
be more likely to develop symptoms of chronic plantar
fasciitis. In a recent case-control study, Irving et al [4]
found that patients with chronic heel pain (defined as
>6 months of symptoms) were nearly 4 times more likely
(odds ratio 3.7, 95% confidence interval 1.6e8.7) to have
a pronated foot posture, determined with FPI. Our find-
ings are in close agreement with these results, because
442 Treatment Response to Nonchronic Plantar Fasciitisour patients with nonchronic plantar fasciitis and heel
valgus were 4 times less likely to respond to patient-
directed treatment measures. These findings make
some intuitive sense, because excessive pronation of the
foot increases tensile loads on the plantar fascia [31,32].
It is also possible that an everted heel may allow for more
displacement of the plantar calcaneal fat pad, and
therefore possibly less shock absorption during impact
(ie, heel strike). Indeed, we examined our data for other
foot types that were poor shock attenuators. We found
uncompensated rearfoot varus was prevalent at 30%;
however, its association with treatment response only
trended towards significance (P ¼ .12).
Outside of heel valgus and a tight gastro-soleal
complex, we did not find any other biomechanical
measurements associated with treatment response.
Although hamstring tightness has been implicated in the
development of plantar fasciitis in previous work [33],
hip flexion did not seem to correlate with likelihood of
achieving a favorable response in our work. This finding
was not entirely unexpected; however, because there
was no effort made during any of our offered therapies
to address a possible contracture of the proximal limb
posterior muscles. Further work to address whether
therapies aimed at relieving hamstring tightness for
plantar fasciitis may be warranted. We were surprised
by our findings that hallux limitus or functional hallux
limitus were not associated with treatment response,
especially given our novel findings of poorly fitting shoes
at baseline. When measuring from heel-to-ball of foot,
only 11% presented with appropriately fitting shoes with
61% having 1 size difference when the heel-to-ball of
foot measure was used. As the plantar medial fascial
band is the widest band of tissue, we were surprised
hallux limitus was not associated with treatment
response. In a case control study, Aranda and Munuera
[34] reported significantly more first metatarsal
phalangeal joint dorsiflexion in controls than those with
plantar fasciitis (71 versus 49).
Finally, we found that patients with severe (>7/10)
first-step heel pain were approximately 4 times more
likely to respond favorably to conservative treatment
measures. This means that patients presenting for
treatment of mild-to-moderate symptoms were less
responsive to conservative therapies for heel pain. In a
largely self-limiting condition with a high placebo
treatment effect [1], it is not surprising to see that
patients with the greatest pain may be more likely to
experience relief with the introduction of relatively
straight-forward program of footwear, insole, and
gentle stretching recommendations.
This work also identified several variables that are, at
least, modestly associated with greater amounts of pain
and/or disability in patients presenting with plantar
fasciitis. We found that patients with greater amounts
of equinus and greater BMI also were more likely to
present with greater average heel pain levels and moreself-reported foot disability. These findings add further
supportive evidence to the notion that ankle equinus
and BMI may be important risk factors in the causal
pathway for developing plantar fasciitis [4,27].
The primary strength of this study is that it is the first
to look at presenting factors that might be predictive of
treatment response in patients suffering with non-
chronic plantar fasciitis. Because pain response was not
associated with the type of foot orthoses received, we
were able to readily evaluate factors that were pre-
dictive of pain response independent of treatment
allocation. The complete examination performed pro-
spectively at presentation by a single experienced
physician allowed for the consideration of many vari-
ables. because all subjects received the same shoes and
the same instructions on stretching and icing, those
aspects were standardized.
We recognize limitations exist and should be addressed
in future studies. The primary weakness of the study is
that it is a secondary analysis. It would be beneficial to
reproduce these findings by the use of a prospective
design and in another, larger patient population. Addi-
tionally, ankle equinus was only measured during the
screening session. It would be interesting to follow po-
tential flexibility improvements in all participants after
the initiation of the included stretching protocol. It would
also be valuable to look at the potential additive benefit
that might be achieved with greater stretching in those
that exhibit the greatest posterior group tightness. All of
the measures were determined by a sole examiner.
Intrarater reliability for measures of the foot and ankle
tend to be quite greater than interrater reliability [35].
However, many of these measures do not have published
clinical effect sizes to assist in determining the clinical
significance of our findings. Lastly, there were a sub-
stantially greater number of female participants and the
potential effect of this is unknown.Conclusion
Patients with severe ankle equinus were nearly
4 times more likely to experience a favorable response
to a plantar fasciitis treatment program that centered
on a home Achilles tendon stretching regimen and
conservative therapy. Patients presenting with more
pronated foot types and less severe presenting pain
were also less likely to respond to conservative care
consisting of ankle stretching, ice massage, standard-
ized shoes, and altering footwear behaviors.References
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